Marine Leblond

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


9 publications

 
NFAT5 induction by the tumor microenvironment enforces CD8 T cell exhaustion
Tillé Laure, Cropp Daniela, Bodley Gabrielle, Andreatta Massimo, Charmoy Mélanie, Crespo Isaac, Nassiri Sina, Lourenco Joao, Leblond Marine, Lopez-Rodriguez Cristina et al..
Development of Traceable Mouse Models of Advanced and Metastatic Bladder Cancer.
Desponds E., Kioseoglou K., Zdimerova H., Ongaro M., Verdeil G., Leblond M.M., 2024/06/17. Cancers, 16 (12). Peer-reviewed.
Immuno-Transcriptomic Profiling of Blood and Tumor Tissue Identifies Gene Signatures Associated with Immunotherapy Response in Metastatic Bladder Cancer.
Desponds E., Croci D., Wosika V., Hadadi N., Fonseca Costa S.S., Ciarloni L., Ongaro M., Zdimerova H., Leblond M.M., Hosseinian Ehrensberger S. et al., 2024/01/19. Cancers, 16 (2) p. 433. Peer-reviewed.
 
Flow cytometry detection and quantification of circulating leukocyte subpopulations in mice after brain irradiation.
Coupey J., Leblond M.M., Hue E.S., Valable S., 2024. Methods in cell biology, 189 pp. 135-152. Peer-reviewed.
Activation of the transcription factor NFAT5 in the tumor microenvironment enforces CD8+ T cell exhaustion.
Tillé L., Cropp D., Charmoy M., Reichenbach P., Andreatta M., Wyss T., Bodley G., Crespo I., Nassiri S., Lourenco J. et al., 2023/10. Nature immunology, 24 (10) pp. 1645-1653. Peer-reviewed.
 
Helicobacter pylori infection has a detrimental impact on the efficacy of cancer immunotherapies.
Oster P., Vaillant L., Riva E., McMillan B., Begka C., Truntzer C., Richard C., Leblond M.M., Messaoudene M., Machremi E. et al., 2022/03. Gut, 71 (3) pp. 457-466. Peer-reviewed.
Tumor-Associated Macrophages in Bladder Cancer: Biological Role, Impact on Therapeutic Response and Perspectives for Immunotherapy.
Leblond M.M., Zdimerova H., Desponds E., Verdeil G., 2021/09/21. Cancers, 13 (18) p. 4712. Peer-reviewed.
 
CD40 Agonist Restores the Antitumor Efficacy of Anti-PD1 Therapy in Muscle-Invasive Bladder Cancer in an IFN I/II-Mediated Manner.
Leblond M.M., Tillé L., Nassiri S., Gilfillan C.B., Imbratta C., Schmittnaegel M., Ries C.H., Speiser D.E., Verdeil G., 2020/09. Cancer immunology research, 8 (9) pp. 1180-1192. Peer-reviewed.
Maf deficiency in T cells dysregulates T<sub>reg</sub> - T<sub>H</sub>17 balance leading to spontaneous colitis.
Imbratta C., Leblond M.M., Bouzourène H., Speiser D.E., Velin D., Verdeil G., 2019/04/16. Scientific reports, 9 (1) p. 6135. Peer-reviewed.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Swiss University